- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01828229
Consequences of Human Inactivity
Epidemiological studies as well as both longitudinal animal and human inactivity studies indicate that low physical activity is associated with the pathophysiology of type 2 diabetes mellitus (T2DM) and obesity, and recently it has been estimated that physical inactivity (worldwide) causes 7% of the burden of disease related to e.g. T2DM. Physical inactivity, a high energy dietary intake, and T2DM are also associated with dementia, depression, and impaired cognitive function. It is critical that we understand how inactivity alters body composition, glucose and lipid metabolism, and cognitive function, if normal physical activity can prevent these changes, and if there are any differences between sexes.
The present protocol is divided in several in several sub-studies:
- To test whether and how a physically inactive lifestyle will influence body composition, glucose and lipid metabolism, and cognitive function.
- To test whether normal physical activity can prevent the deleterious effect of a physically inactive lifestyle despite a high-caloric intake.
- To test whether the influence of a physically inactive lifestyle combined with a high-caloric intake differs between sexes.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark
- Center og inflammation and metabolism, Rigshospitalet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Normal physical active
- Healthy
- 18-40 y of age
- Non-smokers
Exclusion Criteria:
- Pregnancy
- Diabetes in family
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: female inactivity and hypercaloric diet
inactivity and hypercaloric diet in women for two weeks
|
female inactivity and hypercaloric diet for 2 weeks
|
|
Experimental: inactivity
Inactivity for two weeks
|
inactivity for 2 weeks
|
|
Experimental: inactivity and hypercaloric diet
inactivity and hypercaloric diet for two weeks
|
inactivity and hypercaloric diet for 2 weeks
|
|
Experimental: normal activity and hypercaloric diet
Normal activity and hypercaloric diet for two weeks
|
normal activity and hypercaloric diet for 2 weeks
|
|
Active Comparator: inactivity and iso-caloric diet
inactivity and iso-caloric diet for two weeks
|
inactivity and iso-caloric diet for 2 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin sensitivity
Time Frame: 2 weeks
|
Area under the curve of plasma glucose and insulin levels during an oral glucose tolerance test
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
visceral adiposity
Time Frame: 2 weeks
|
Amount of visceral fat is determined by MRI scans
|
2 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive function
Time Frame: 2 weeks
|
Assessed by the Conner's Continuous Performance Test II 2000
|
2 weeks
|
|
aerobic fitness
Time Frame: 2 weeks
|
maximal oxygen uptake (VO2max) was measured during an incremental exercise test performed on a cycle ergometer
|
2 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Olsen RH, Krogh-Madsen R, Thomsen C, Booth FW, Pedersen BK. Metabolic responses to reduced daily steps in healthy nonexercising men. JAMA. 2008 Mar 19;299(11):1261-3. doi: 10.1001/jama.299.11.1259. No abstract available.
- Krogh-Madsen R, Thyfault JP, Broholm C, Mortensen OH, Olsen RH, Mounier R, Plomgaard P, van Hall G, Booth FW, Pedersen BK. A 2-wk reduction of ambulatory activity attenuates peripheral insulin sensitivity. J Appl Physiol (1985). 2010 May;108(5):1034-40. doi: 10.1152/japplphysiol.00977.2009. Epub 2009 Dec 31. Erratum In: J Appl Physiol. 2010 May;108(5):1034.
- Knudsen SH, Hansen LS, Pedersen M, Dejgaard T, Hansen J, Hall GV, Thomsen C, Solomon TP, Pedersen BK, Krogh-Madsen R. Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men. J Appl Physiol (1985). 2012 Jul;113(1):7-15. doi: 10.1152/japplphysiol.00189.2011. Epub 2012 May 3. Erratum In: J Appl Physiol (1985). 2015 Feb 15;118(4):504.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-4-2009-082
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on female inactivity and hypercaloric diet
-
University of CopenhagenNovo Nordisk A/S; Queen Mary University of London; University of SydneyNot yet recruitingInsulin Sensitivity/Resistance | Metabolic HealthDenmark
-
Maimónides Biomedical Research Institute of CórdobaCompleted
-
Western Michigan UniversityHillblom Foundation; Commonwealth of the Northern Marianna Islands Public School...Completed
-
University of AarhusCompletedGestational DiabetesDenmark
-
Amsterdam UMC, location VUmcAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)CompletedObesity | Insulin Resistance | Type 2 DiabetesNetherlands
-
Centre Hospitalier Universitaire VaudoisUniversity of LyonUnknownObesity | DiabetesSwitzerland
-
Université de SherbrookeHospices Civils de LyonCompleted
-
Centre Hospitalier Universitaire VaudoisCompletedFemale Reproductive System DisorderSwitzerland
-
George Washington UniversityTerminatedAdiposity | Impaired Glucose Tolerance | Insulin Sensitivity | Metabolic DisturbanceUnited States
-
University of Missouri-ColumbiaCompletedVascular DiseasesUnited States